A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

NCT01349101 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Hematological Malignancies

Interventions

RADIATION: Total Body Irradiation
DRUG: Cyclophosphamide
DRUG: Tacrolimus
DRUG: Mycophenolate mofetil
DRUG: Fludarabine
DRUG: Busulfan
GENETIC: Hematopoietic stem cell transplantation

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University